MedPath

THERAPY FORMULAS MULTI-ENZYME FORMULA-CAP

THERAPY FORMULAS MULTI-ENZYME FORMULA-CAP

Discontinued
DIN Number

02216736

Drug Class

Human

Market Date

Oct 15, 2001

Company
HC

general nutrition canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02216736
AIG Number0928568001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:16.00
Health Canada Classification

ACTIVE INGREDIENTS (9)

AMYLASEActive
Strength: 50 MG
Monograph: AMYLASE
BROMELAINActive
Strength: 50 MG
Monograph: BROMELAIN
CELLULASEActive
Strength: 50 MG
Monograph: CELLULASE
DIASTASEActive
Strength: 50 MG
Monograph: DIASTASE
HEMICELLULASEActive
Strength: 50 MG
Monograph: HEMICELLULASE
LACTASEActive
Strength: 50 MG
Monograph: LACTASE
LIPASEActive
Strength: 50 MG
Monograph: LIPASE
PAPAINActive
Strength: 50 MG
Monograph: PAPAIN
PROTEASEActive
Strength: 50 MG
Monograph: PROTEASE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.